Vote Scores
Filings read through

Akebia Therapeutics, Inc.: how funds voted at the meeting of 6 Jun 2024

Ticker
AKBA
Meeting
Season
year to 30 June 2024
Filers reporting
92
Ballot items
4

92 filers on Form N-PX reported votes at the Akebia Therapeutics, Inc. meeting of 6 Jun 2024. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of Akebia Therapeutics, Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2024. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    3 nominees. 87.5% of the reported votes are for. 7 filers withheld from or voted against at least one nominee.

    64 vote records from 18 filers. 2 of the 18 filers that marked the item voted against management.

    • Positions of 11 fund families
    • For 10
    • Abstain or withhold 1
    • Against management 1
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    108 vote records from 90 filers. 15 of the 85 filers that marked the item voted against management. 5 filers gave no management mark.

    • Positions of 18 fund families
    • For 15
    • Against 3
    • Against management 3
  3. Item 3: Audit-related items (auditor ratification)

    21 vote records from 17 filers. 1 of the 17 filers that marked the item voted against management.

    • Positions of 11 fund families
    • For 11
  4. Item 4: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    24 vote records from 20 filers. 0 of the 20 filers that marked the item voted against management.

    • Positions of 11 fund families
    • For 11

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Akebia Therapeutics, Inc., meeting of 6 Jun 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor
BlackRock and iSharesForFor
BNY MellonForNo report
Charles SchwabForFor
Federated HermesAgainst, against managementFor
FidelityForFor
Goldman SachsForNo report
Guggenheim and RydexForFor
InvescoForFor
Janus HendersonForNo report
John Hancock and ManulifeForFor
NationwideForFor
Northern Trust and FlexSharesForNo report
PGIM and PrudentialAgainst, against managementNo report
Russell InvestmentsAgainst, against managementFor
State Street and SPDRForNo report
T. Rowe PriceForNo report
VanguardForFor
Victory CapitalForFor

Questions

How many filers reported votes at the Akebia Therapeutics, Inc. meeting?
92 Form N-PX filers reported votes at the meeting of 6 Jun 2024. On say-on-pay, 15 of 85 filers that marked the item voted against management (17.6%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Akebia Therapeutics, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Akebia Therapeutics, Inc. with a meeting date within three days of 6 Jun 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .